Skip to main content

Table 1 Baseline characteristics

From: Changes in lipoprotein lipase and endothelial lipase mass in familial hypercholesterolemia during three-drug lipid-lowering combination therapy

 

All (n = 16)

Group 1 (n = 9)

Group 2 (n = 7)

Age (yr)

63 ± 10

60 ± 11

68 ± 7

Male (n,%)

11 (69 %)

4 (44 %)

5 (71 %)

Body mass index (kg/m2)

23.7 ± 2.0

23.1 ± 1.9

24.5 ± 1.9

Total cholesterol (mg/dl)

380 ± 42

394 ± 56

364 ± 51

Triglyceride (mg/dl)

95 [84–127]

95 [88–126]

91 [68–136]

HDL cholesterol (mg/dl)

46 ± 10

49 ± 14

43 ± 6

LDL cholesterol (mg/dl)

299 ± 48

309 ± 46

283 ± 48

RLP cholesterol (mg/dl)

8.9 ± 3.3

8.7 ± 3.5

9.2 ± 3.0

Hypertension (n, %)

8 (50 %)

3 (33 %)

5 (71 %)

Diabetes (n, %)

6 (38 %)

3 (33 %)

3 (43 %)

Smoking (n, %)

1 (6 %)

0 (0 %)

1 (14 %)

Coronary artery disease (n, %)

9 (56 %)

4 (44 %)

5 (71 %)

  1. RLP remnant-like particle